Key result
Absolute iron deficiency is linked to ~2.2-fold higher 90-day death or readmission risk in acute heart failure.
Why the study?
Iron deficiency is an under-recognized comorbidity associated with poor outcomes in acute heart failure, but data on its impact on short-term outcomes among patients in Tanzania were limited.
Cohort (n=330)
No
Among patients admitted with acute heart failure in Tanzania, absolute iron deficiency is present in over half of patients and independently more than doubles the risk of 90-day mortality or readmission while worsening functional recovery and prolonging hospital stay.
Answers are grounded in this paper and cite their sources.
Should not yet guide iron repletion in acute heart failure; leaves open whether correction improves 90-day outcomes.
Introduction: Iron deficiency is a common but under-recognized comorbidity in acute heart failure (AHF) and is associated with poor outcomes. However, data on its impact on short-term outcomes among AHF patients in Tanzania remain limited. This study assessed the association between absolute iron deficiency (AID) and short-term outcomes among patients admitted with AHF at Benjamin Mkapa Hospital (BMH). Methods A prospective cohort study was conducted among adults admitted with AHF at BMH between January 2025 and June 2026. AID was defined as serum ferritin < 100 ng/mL. Participants were followed for 90 days. The primary outcome was a composite of all-cause mortality or hospital readmission. Secondary outcomes included quality of life (KCCQ-12 score), NYHA functional status, and length of hospital stay. Kaplan-Meier and Cox regression assessed the primary outcome; secondary outcomes were compared using parametric or non-parametric tests as appropriate. Results A total of 339 participants were enrolled, of whom 330 (97.3%) completed follow-up. The mean age was 61.5 ± 15.5 years, 176 (53.0%) were female and 175 (53.0%) participants had AID. During follow-up, 63 (19.0%) experienced the composite endpoint. Participants with AID had lower event-free survival than those without (72.5% vs. 90.3%, log-rank p < 0.001). After adjustment, AID was independently associated with the composite endpoint (AHR 2.25, 95% CI 1.21–4.17; p = 0.010). At 90 days, AID participants had poorer NYHA functional status, with more remaining in class IV (20.0% vs. 11.6%) and fewer reaching class II (28.0% vs. 37.4%; χ²=21.20, p < 0.001). Participants with AID had a smaller improvement in KCCQ-12 scores (4.1 ± 9.8 vs. 9.2 ± 8.8 points; p < 0.001), and hospital stay was longer (7.9 ± 2.5 vs. 6.8 ± 2.2 days; p < 0.001). Conclusion AID is common among patients admitted with AHF and is independently associated with poorer short-term clinical outcomes. Larger multicentre studies with longer follow-up are needed to confirm these findings.
No takes yet. Share an insight, caveat, or question.
Mukky¹ et al. (2026) conducted a cohort in Acute heart failure (n=330). Absolute iron deficiency (serum ferritin < 100 ng/mL) vs. No absolute iron deficiency (serum ferritin >= 100 ng/mL) was evaluated on Composite of all-cause mortality or hospital readmission (event-free survival at 90 days) (AHR 2.25, 95% CI 1.21-4.17, p=0.010). Absolute iron deficiency was independently associated with a higher risk of all-cause mortality or hospital readmission at 90 days in acute heart failure.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: